Novel PPAR Pan Agonist, ZBH Ameliorates Hyperlipidemia and Insulin Resistance in High Fat Diet Induced Hyperlipidemic Hamster

Open Access

Peer-reviewed

Research Article

Wei Chen ,

Contributed equally to this work with: Wei Chen, Shiyong Fan

Affiliation Beijing Institute of Pharmacology and Toxicology, Beijing, China
⨯
Shiyong Fan ,

Contributed equally to this work with: Wei Chen, Shiyong Fan

Affiliation Beijing Institute of Pharmacology and Toxicology, Beijing, China
⨯
Xinni Xie,

Affiliation Beijing Institute of Pharmacology and Toxicology, Beijing, China
⨯
Nina Xue,

Affiliation Beijing Institute of Pharmacology and Toxicology, Beijing, China
⨯
Xueyuan Jin ,

* E-mail: xueyuanjin@yahoo.com (XYJ); wangll63@126.com (LLW)

Affiliation International Center for Liver Disease Treatment, Beijing 302 Hospital, Beijing, China
⨯
Lili Wang

* E-mail: xueyuanjin@yahoo.com (XYJ); wangll63@126.com (LLW)

Affiliation Beijing Institute of Pharmacology and Toxicology, Beijing, China
⨯

Reader Comments (0)

Hamsters
Is the Subject Area "Hamsters" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Fatty acids
Is the Subject Area "Fatty acids" applicable to this article?

Thanks for your feedback.
Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Adipose tissue
Is the Subject Area "Adipose tissue" applicable to this article?

Thanks for your feedback.
Fatty liver
Is the Subject Area "Fatty liver" applicable to this article?

Thanks for your feedback.
Dyslipidemia
Is the Subject Area "Dyslipidemia" applicable to this article?

Thanks for your feedback.
Lipids
Is the Subject Area "Lipids" applicable to this article?

Thanks for your feedback.